Navigation Links
Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes
Date:5/29/2008

cy to launder the proceeds of their crimes; and four counts of money laundering. Garcia also was charged with four counts of submitting false claims to the Medicare program. If convicted on all charged counts, Garcia faces a maximum of 85 years in prison. Freire faces a maximum of 65 years in prison if convicted on all charges.

Another separate indictment alleges that between November 2002 and April 2004, Dr. Carlos Contreras, 60, and Dr. Ramon Pichardo, 58, conspired to submit approximately $6.8 million in false and fraudulent claims to the Medicare program for HIV infusion services allegedly provided at C.N.C. Medical Corp., an HIV infusion clinic at which Contreras and Pichardo were both physicians. As part of the scheme, Contreras, Pichardo and their co-conspirators would cause unnecessary tests to be ordered, medical forms to be signed and treatments to be authorized to make it appear that legitimate HIV infusion services were being provided at C.N.C Medical. They would then cause the payment of cash kickbacks to Medicare beneficiaries in exchange for the patients signing documents stating that they received the treatments being billed to Medicare, when in reality such treatments were not provided and not medically necessary. The indictment also alleges that Contreras and Pichardo laundered the proceeds of their crimes by sending proceeds to sham management and marketing companies owned and controlled by their co-conspirators and by sending proceeds to a company owned and controlled by Pichardo.

Contreras and Pichardo are charged with one count of conspiracy to defraud the United States, to cause the submission of false claims to the Medicare program, and to pay health care kickbacks; one count of conspiracy to commit health care fraud; one count of conspiracy to launder the proceeds of their crimes; and three counts each of money laundering. Contreras was also charged with three counts of submitting false claims to the Medicare program. If convic
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Alsius Corporation Awarded Three-Year Agreement With Premier, Inc.
2. The Doctors Channel Launches New Videos from Three Top Hospitals
3. Alsius Corporation Awarded Three-Year Agreement with HealthTrust Purchasing Group
4. Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
5. ABMS Assembly Votes in Favor of Three-Year Initiative to Enhance Public Trust in the Board Certification Process
6. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
7. Three-Day Strike by Hundreds of Security Officers at Kaiser Hospitals Succeeds in Raising Red Flag About Unfair Labor Practices
8. Independence Blue Cross, Jefferson Health System Reach Agreement on New Three-Year Contracts
9. Amneal Pharmaceuticals Receives US FDA Approval for Three Generic Prescription Drugs; Two Using New FDA Electronic Filing Format
10. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
11. Wal-Mart Launches Phase Three of $4 Prescription Program
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:Prostate Hormone Therapy May Up Heart Risks 2Health News:Prostate Hormone Therapy May Up Heart Risks 3Health News:New approach to sickle-cell disease shows promise in mice 2
Other Medicine News:Health News:Prescription labels geared toward pharmacies, not patients 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 3Health News:New HIV diagnoses rising in New York City among young men who have sex with men 4Health News:Additional Top Tier Institutions Implement Mediware's HCLL(TM) Transfusion Management Software 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 3Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 2Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 3Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 4Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 2Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 3
Breaking Medicine Technology:Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 1Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 2Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 3Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 4Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 5Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 6Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 7Scientist Who Helps Explain Pain Wins Grawemeyer Award 62392 1Scientist Who Helps Explain Pain Wins Grawemeyer Award 62392 2Patient Safety Technologies Inc Appoints Marc L Rose CPA 28PA 29 Chief Financial Officer 6662 1Patient Safety Technologies Inc Appoints Marc L Rose CPA 28PA 29 Chief Financial Officer 6662 2